Search Results
Sep 01, 2026, 06:00 ET IDEAYA Biosciences Announces London Investor R&D Day and Participation in Upcoming September 2026 Investor Conferences
Yujiro S. Hata, Chairman and Chief Executive Officer, and Joshua Bleharski, Chief Financial Officer, hosted by Yigal D. Nochomovitz, Ph.D., Director, SMid Cap Biotech AnalystMorgan Stanley 24th Annual Global Healthcare ConferenceMonday, September 14th,
More news about: IDEAYA Biosciences, Inc.
Jul 29, 2026, 12:59 ET Conestoga Capital Advisors Reopens Small Cap Fund Following Capacity Review
LLCHeadquartered in Wayne, Pennsylvania, Conestoga Capital Advisors, an independent investment advisory firm, manages over $5.4 billion in Small-, SMid-, and Micro Cap Growth company portfolios for both institutional and individual investors as of June 30, 2026. Since its founding in 2001, Conestoga
More news about: Conestoga Capital Advisors, LLC
May 20, 2026, 10:18 ET American Capital Management Names Ross Weissman Chief Operating Officer and Chief Financial Officer
Executive Officer, and Chief Investment Officer of ACM. "His experience will be a tremendous asset as we continue to strengthen ACM's Small Cap and SMID Cap Equity Growth platform and position the firm for long-term success."Mr. Weissman added, "I am excited to join ACM and work alongside such
More news about: American Capital Management
Apr 30, 2026, 16:15 ET Huntsman Announces First Quarter 2026 Earnings
the second quarter 2026, a member of management is expected to present at:TPH&Co. Hotter 'N Hell Conference, May 12, 2026Mizuho Smid Cap Chemicals Conference, June 2, 2026 Deutsche Bank Global Industrials & Materials Conference, June 3, 2026A webcast of the presentation,
More news about: Huntsman Corporation
Apr 09, 2026, 07:00 ET Businesses face sustained pressure in 2026 as global insolvencies rise 3%, Atradius forecasts
According to Atradius Senior Economist Theo Smid, "Our insolvency forecast has deteriorated due to the persistence of adverse economic conditions, including Covid‑related tax debts, rising input costs
More news about: Atradius N.V.
Apr 09, 2026, 06:42 ET Businesses face sustained pressure in 2026 as global insolvencies rise 3%, Atradius forecasts
According to Atradius Senior Economist Theo Smid, "Our insolvency forecast has deteriorated due to the persistence of adverse economic conditions, including Covid‑related tax debts, rising input costs
More news about: Atradius N.V.
Apr 09, 2026, 06:42 ET Les entreprises restent sous pression en 2026, confrontées une augmentation des défaillances mondiales de 3 %
Selon Theo Smid, Economiste chez Atradius : « Nos prévisions des défaillances se sont détériorées en raison de la persistance de conditions économiques défavorables,
More news about: Atradius N.V.
Apr 08, 2026, 14:29 ET SMArtX Advisory Solutions Expands Manager Marketplace with Investment Strategies from 20 Leading Asset Management Firms
market."New strategies available:Alta Capital ManagementQuality Dividend GrowthSelect StrategySMID StrategyFiera Capital, Inc.U.S. Large Cap GrowthFirst EagleGlobal
More news about: SMArtX Advisory Solutions
Mar 18, 2026, 09:00 ET PIMCO Recognized as 2026 Asset Manager of the Year by Envestnet
ETFPIMCO Income FundU.S. Large & All CapWakefield Large Cap Equity SMAU.S. Small, SMID, and Mid CapEastern Shore Small Cap Equity SMAInternational, Emerging Markets, and Global Equity
More news about: Envestnet
Feb 28, 2026, 00:51 ET Navigara Launches the Performance Layer for Enterprise Engineering Teams and AI Tools Backed by $2.5M
States. Combining deep technical expertise with a clear vision for international growth is, in our view, a key prerequisite for success," says Petr Šmíd, General Partner at Rockaway Ventures.About NavigaraNavigara is the performance layer for modern engineering, connecting GitHub,
More news about: Navigara
Feb 26, 2026, 17:53 ET AZZ Inc. Announces March Investor Conference Schedule
Officer, will present on Tuesday, March 2, at 2:15 pm ET, and will host one-on-one investor meetings on March 2-3, 2026.The Citadel Securities SMID Cap Conference held at the 1 Hotel, Miami, FL, on March 4-5, 2026. David Nark will participate in one-on-one investor meetings on Thursday, March 5,
More news about: AZZ, Inc.
Feb 25, 2026, 16:11 ET SM ENERGY PROVIDES 2026 OUTLOOK
Pursell will present at 9 a.m. MT/11 a.m. ET and will participate in investor meetings at the event.March 4, 2026 – Citadel SMID Cap Generalist Investor Conference. President and Chief Executive Officer Beth McDonald and Executive Vice President and Chief Financial Officer
More news about: SM Energy Company
Feb 03, 2026, 10:30 ET Global Bond Market to Reach USD 167.5 Trillion by 2031 Led by Treasury Bonds, Real Estate & REITs: Mordor Intelligence
transportation-related segments. Based on investment size, the market covers large-cap deals, upper and lower middle-market investments, and small and SMID transactions. Geographically, private equity activity extends across North America, South America, Asia-Pacific, Europe, and the Middle East and Africa,
More news about: Mordor Intelligence Private Limited
Feb 02, 2026, 06:00 ET IDEAYA Biosciences to Participate in Upcoming February 2026 Investor Relations Events
Medical Officer; Michael White, Chief Scientific Officer; and Joshua Bleharski, Chief Financial Officer, hosted by Yigal D. Nochomovitz, Ph.D., Director, SMid Cap Biotech AnalystIDEAYA Biosciences' Virtual Fireside Chat hosted by Umer Raffat of Evercore ISIMonday, February 23rd,
More news about: IDEAYA Biosciences, Inc.
Jan 28, 2026, 12:45 ET Laborie Acquires the JADA® System for Rapid Postpartum Hemorrhage Control, Expanding Obstetrics Portfolio
https://www.who.int/teams/sexual-and-reproductive-health-and-research-%28srh%29/areas-of-work/maternal-and-perinatal-health/postpartum-haemorrhage2 D'Alton ME, Rood KM, Smid MC, et al. Intrauterine Vacuum‑Induced Hemorrhage‑Control Device for Rapid Treatment of Postpartum Hemorrhage. Obstet Gynecol. 2020 Nov;136(5):882–891.
More news about: Laborie Medical Technologies
Jan 22, 2026, 08:36 ET Integrity Wealth and Humilis Investment Strategies Announce First U.S. SMA Partnership
five U.S.-based portfolios that offer a diverse pool of long-term growth opportunities and emerging trends: Dividend Growth, Large Cap Value, All Cap, SMID Focused and U.S. Focused. They will also gain access to Humilis' independent market research and industry reports to identify investment opportunities.Humilis
More news about: Integrity Marketing Group, LLC
Jan 22, 2026, 03:39 ET Private Equity Market to Exceed USD 37 Trillion by 2031 Globally, Led by Buyout Strategies and Large-Cap Deals, Reports Mordor Intelligence
etc.) By Investments Large Cap Upper Middle Market Lower Middle Market Small & SMID By Geography North America South America Asia-Pacific Europe Middle
More news about: Mordor Intelligence Private Limited
Jan 14, 2026, 07:45 ET Callan's 2025 Investment Management Fee Study Uncovers What Institutional Investors Are Actually Paying
fund-of-funds, global ex-U.S. equity, and emerging equityFee weakness affected core-plus fixed income, U.S. smid/small/macro, high yield/bank loans, and emerging debtPassive usage in U.S. smid/small/micro cap equity increased 6% from 2023 to 29%, while passive usage for core fixed Income increased
More news about: Callan LLC
Jan 05, 2026, 06:00 ET IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference
Presentation by Yujiro S. Hata, Chief Executive Officer, IDEAYA Biosciences, followed by analyst-hosted Q&A with Anupam Rama, Managing Director, US SMID Biotechnology Equity Research, J.P. MorganA live audio webcast of the presentation and Q&A session will be available under the "Investors/Events"
More news about: IDEAYA Biosciences, Inc.
Dec 23, 2025, 17:23 ET Intech S&P Mid Cap Diversified Alpha ETF Surpasses $100 Million; Performance Underscores Structural Edge in SMID-Cap Core
multimedia:https://www.prnewswire.com/news-releases/intech-sp-mid-cap-diversified-alpha-etf-surpasses-100-million-performance-underscores-structural-edge-in-smid-cap-core-302618940.htmlSOURCE
More news about: Intech ETFs
Dec 08, 2025, 08:15 ET Granahan Investment Management Named One of Best Places to Work in Money Management by Pensions & Investments for Fifth Consecutive Year
ownership and approximately $2.5 billion in assets under management and advisement as of Sept. 30, 2025. The firm offers U.S. microcap, small cap, and SMID strategies for institutions and high net worth individuals worldwide. For more information, visit
More news about: Granahan Investment Management
Nov 24, 2025, 06:00 ET IDEAYA Biosciences to Participate in Upcoming December 2025 Investor Relations Events
ETFireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by Yigal D. Nochomovitz, Ph.D., Director, SMid Cap Biotech Analyst8th Annual Evercore Healthcare ConferenceWednesday, December 3rd, 2025 at 10:50 AM ETFireside
More news about: IDEAYA Biosciences, Inc.
Nov 18, 2025, 08:00 ET Tom Lee's Fundstrat Capital Expands Granny Shots ETF Lineup-- GRNJ and GRNI Will Begin Trading Today on NYSE Arca
Nov. 18, 2025 /PRNewswire/ -- Fundstrat Capital announces the launch of the Fundstrat Granny Shots US Small- & Mid-Cap ETF ("SMID Granny") (Ticker: GRNJ) and the Fundstrat Granny Shots US Large Cap & Income ETF ("Granny Income") (Ticker: GRNI), both of which will begin trading
More news about: Fundstrat Capital
Nov 11, 2025, 08:00 ET Tom Lee's Fundstrat Capital Announces Two New Granny Shots ETFs -- GRNJ and GRNI -- Expected to Soon Commence Trading on NYSE Arca
& Mid-Cap ETF ("SMID Granny") (NYSE: GRNJ) and the Fundstrat Granny Shots US Large Cap & Income ETF ("Granny Income") (NYSE: GRNI) are expected to commence trading soon on NYSE Arca. These two new ETFs broaden and strengthen Fundstrat's Granny Shots ETF family, adding a SMID and an income-oriented
More news about: Fundstrat Capital
Oct 27, 2025, 06:00 ET IDEAYA Biosciences to Participate in Upcoming November 2025 Investor Relations Events
Citi's 2025 SMID Cap Biopharma Call SeriesThursday, November 6th, 2025 at 12:00 PM ET Fireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by Yigal D. Nochomovitz, Ph.D., Director, SMid Cap Biotech
More news about: IDEAYA Biosciences, Inc.